Highlight Keynote Presentation Not Just a Message: Noncoding RNAs in Biology and Medicine Thomas R. Cech, Ph.D. Distinguished Professor, University of Colorado-Boulder; Nobel Laureate, 1989 (Chemistry) Sponsored by

Keynote Presentations

	Human Genetics and Oligonucleotides: Essential Partners in Pharma's Future Arthur M. Krieg, M.D. Chief Scientific Officer, Research Technology Center, Pfizer Inc		Peptide Therapeutics: Trends in Global Clinical Development and Approval Janice M. Reichert, Ph.D. Senior Research Fellow, Tufts Center for the Study of Drug Development; Editor-in-Chief, mAbs, Landes Bioscience
	Therapeutic Strategies Using RNA Interference John J. Rossi, Ph.D Lidow Family Research Chair, Professor, Division of Molecular Biology; Dean, Graduate School of Biological Sciences; Beckman Research Institute of City of Hope		Taking Advantage of Peptide Aggregation Joel P. Schneider, Ph.D. Associate Professor, Department of Chemistry and Biochemistry, Department of Materials Science and Engineering, University of Delaware

• 経済ならびに規制によるリスクを緩和するための規制戦略: Lilly、Avecia OligoMedicines、OncoGenex、 Ipsen、 Millennium、Pfizerの事例に学ぶ
• New! 注目の新テクノロジー
  • 新たな化学特性が潜在的ライセンス供与の市場機会と将来の製造ニーズを方向づける
  • 潜在的市場の対象を広げる新たな薬物送達技術
  • 製品品質と製造効率向上のためのスプ噴霧乾燥技術: オリゴヌクレオチド、ペプチドを例として
  • ベンゾトリアゾール系カップリング試薬の非爆発性代替物質
  • 翻訳開始阻害オリゴヌクレオチドとそのペプチド共役技術がマイクロRNAへの標的化の向上させる
  • 生産効率化に寄与するソリッドまたはリキッドフェーズ合成技術
• 複合分子の分析技術
  • 各社の技術ならびに規制戦略:　特性の改善と品質管理の工場　 Merck、Bristol-Myers、U. of Washington、Regado、 Alnylam、Isis
• 2日間に亘るトラック: パイプライン上有力な候補物質の最新情報、送達から前臨床ならびに臨床開発への進展について
  • microRNA、siRNA、LNA、　ターゲット送達、 SNALP、アプタマー、 Once-Daily GLP-1 Analog、抗肥満ペプチド吸入剤、PEG代替物、 補体阻害剤、pepducins、 IpsenとRocheのGLP-1 Analogueでの協力体制、Linaclotide, ペプチド共重合体

TIDES® registration also includes access to IBC's 5th International Applications of Nucleic Acids Technologies in Molecular Diagnostics Accelerating Product Development through Cutting Edge Regulatory, Business and Technology Strategies May 19-20, 2009 · Red Rock Casino, Resort & Spa · Las Vegas, NV Keynote Presentations Molecular Diagnostics: Revolution, Regulation and Reimbursement Alberto Gutierrez, Ph.D. Deputy Director, New Product Evaluation, Office of In Vitro Diagnostic Device Evaluation and Safety CDRH, US FDA Molecular Diagnostics: A Key Component of the Future Healthcare Value Chain George Poste, D.V.M., Ph.D. Director, The Biodesign Institute Arizona State University Reagent Solutions to Challenges in Oligonucleotide Diagnostics Steven A. Benner, Ph.D. Distinguished Fellow Foundation for Applied Molecular Evolution Inc.